Marinus Pharmaceuticals, Inc. (MRNS) was a big mover last session with its shares rising nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock is now up over 53% in the past one-month time frame.
Over the last 30 days, this biopharmaceutical company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Dipexium currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
A better-ranked stock in the biomedical industry is Lannett Company, Inc. (LCI) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment